Where it began, I can’t begin to knowing, but with a loose “round-table” feel, panelists took a serious issue and turned it inside out, demonstrating (rather than discussing) the future of collaboration by de-constructing the recent controversy over whether or not the public should have access to the highly addictive new drug, methamusilphenodioxyn, more commonly known by its street name, “Sweet Caroline”. Heralded by some doctors as a miraculous stress-reducer, the drug has been linked to disorientation, temporary hearing loss and baseless celebratory shouting.
The panel reached no definitive conclusion, instead repeating and fading to applause from the sparse but enthusiastic audience.
Good times never seemed so good.
Claims that the entire session was a performance art piece by post-grunge pop-up group, Bella and the Broadstreets require further research.